ATLANTA – Pancreatic and ovarian cancers are two of the deadliest forms of cancer, primarily due to the fact that they aren't diagnosed until late stages. Nanotechnology may offer some early detection solutions and the latest advances were reported at BIO 2009, the annual meeting of the Biotechnology Industry Organization (Washington). (Diagnostics & Imaging Week)

ATLANTA – The reality in life sciences is that you need physician buy in for any new medical technology. The gee whiz factor just doesn't count unless the docs say "OK." That's the conundrum presented by the makers of non-invasive diagnostic tests: a potential boon for patients, but an economic slap for many physician practices. Strategies to overcome these challenges were addressed by a panel at BIO 2009, the annual meeting of the Biotechnology Industry Organization (Washington). (Diagnostics & Imaging Week)

ATLANTA — The reality in life sciences is that you need physician buy in for any new medical technology. The gee whiz factor just doesn't count unless the docs say "OK." (Medical Device Daily)

Build a better surgical tool and, voila, a new med-tech company is born. That's the story behind four-year-old CoreSpine Technologies (Minneapolis), which just received FDA 510(k) clearance for its Xtend-ST Nucleus Removal System, a device intended to replace decades-old rongeurs when used for complete or selective removal of material from the lumbar disc space. (Medical Device Daily)